MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosis.

Koki ShimizuShunsuke HamadaTomohisa SakaiShinji ItoHiroshi UrakawaEisuke AraiKunihiro IkutaHiroshi KoikeNaoki IshiguroYoshihiro Nishida

Published in: Journal of medical imaging and radiation oncology (2019)

MRI characteristics were a useful predictor of the efficacy of meloxicam in DF patients. It may be possible to predict the clinical outcome more accurately when combined with other factors, such as CTNNB1 mutantion status.

Keyphrases

end stage renal disease
magnetic resonance imaging
ejection fraction
newly diagnosed
chronic kidney disease
diffusion weighted imaging
prognostic factors
peritoneal dialysis
computed tomography
patient reported outcomes
combination therapy
smoking cessation